RaySearch Laboratories AB (publ)
RSLBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $332,300 | $304,866 | $331,698 | $322,665 |
| % Growth | 9% | -8.1% | 2.8% | – |
| Cost of Goods Sold | $11,800 | $27,897 | $26,470 | $24,792 |
| Gross Profit | $320,500 | $276,969 | $305,228 | $297,873 |
| % Margin | 96.4% | 90.8% | 92% | 92.3% |
| R&D Expenses | $68,200 | $72,956 | $58,826 | $71,292 |
| G&A Expenses | $73,000 | $71,550 | $67,737 | $72,231 |
| SG&A Expenses | $164,100 | $161,636 | $156,936 | $163,678 |
| Sales & Mktg Exp. | $91,100 | $90,086 | $89,199 | $91,447 |
| Other Operating Expenses | -$1,000 | $6,015 | $14,640 | -$10,676 |
| Operating Expenses | $231,300 | $240,607 | $230,402 | $224,294 |
| Operating Income | $89,200 | $36,362 | $74,826 | $73,579 |
| % Margin | 26.8% | 11.9% | 22.6% | 22.8% |
| Other Income/Exp. Net | -$700 | $3,206 | -$3,808 | $3,858 |
| Pre-Tax Income | $88,500 | $39,568 | $71,018 | $77,437 |
| Tax Expense | $16,900 | $8,806 | $14,211 | $17,441 |
| Net Income | $71,600 | $30,762 | $56,807 | $59,996 |
| % Margin | 21.5% | 10.1% | 17.1% | 18.6% |
| EPS | 2.09 | 0.9 | 1.66 | 1.75 |
| % Growth | 132.2% | -45.8% | -5.1% | – |
| EPS Diluted | 2.09 | 0.9 | 1.66 | 1.75 |
| Weighted Avg Shares Out | 34,283 | 34,180 | 34,283 | 34,283 |
| Weighted Avg Shares Out Dil | 34,283 | 34,180 | 34,283 | 34,283 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3,206 | $0 | $3,858 |
| Interest Expense | $0 | $0 | $3,808 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $89,100 | $36,362 | $74,826 | $73,579 |
| % Margin | 26.8% | 11.9% | 22.6% | 22.8% |